FindTrial
Sign In

Exploration and clinical application of new molecular markers for early accurate diagnosis and treatment of diabetes nephropathy

Exploration and clinical application of new molecular markers for early accurate diagnosis and treatment of diabetes nephropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089961
Enrollment
Unknown
Registered
2024-09-20
Start date
2024-10-01
Completion date
Unknown
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic nephropathy

Interventions

Observation group:None

Sponsors

The People's Hospital of SND
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Diabetes nephropathy confirmed by renal biopsy ; Non diabetes nephropathy confirmed by renal biopsy pathology;

Exclusion criteria

Exclusion criteria: Severe cardiopulmonary dysfunction; Fever;

Design outcomes

Primary

MeasureTime frame
SRGAP2a;ACR;—

Secondary

MeasureTime frame
GBP4;JAK2;RUVBL1;—

Countries

China

Contacts

Public ContactJindonghua

The People's Hospital of SND

jiangzhouhust@163.com+86 189 9442 0822

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026